SciELO - Scientific Electronic Library Online

 
vol.60 issue4Robotic-assisted radical prostatectomy: functional outcomesLaparoscopic radical prostatectomy versus robotic author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Archivos Españoles de Urología (Ed. impresa)

Print version ISSN 0004-0614

Abstract

RODRIGUEZ JR., Esequiel; SKARECKY, Douglas W.  and  AHLERING, Thomas E.. Radical robot prostatectomy: oncological outcomes. Arch. Esp. Urol. [online]. 2007, vol.60, n.4, pp.421-429. ISSN 0004-0614.

Objectives: To review the current literature on oncologic outcomes following robot-assisted laparoscopic radical prostatectomy. Methods: A systematic MEDLINE search was performed to retrieve articles relating to oncologic outcomes with robot-assisted laparoscopic prostatectomy. Two reviewers independently selected studies, assessed their methodological quality and extracted data. Results: Positive surgical margin rates in RALP are commensurate to contemporary open and standard laparoscopic series. Surgical experience and refinement of technique helped decrease positive margins. Long-term biochemical disease-free survival (PSA <0.1 ng/ml) following RALP is currently unknown, with only 2 series reporting data with 12 month follow-up. Conclusions: RALP is a safe and reproducible treatment modality for organ-confined prostate cancer and provides excellent short-term oncological control. Larger studies with long-term oncologic follow-up are needed to establish the efficacy compared to more traditional surgical approaches.

Keywords : Robot-assisted; Laparoscopic radical prostatectomy; Oncological outcomes; Surgical margins; PSA recurrence.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License